MapLight Therapeutics, Inc. (MPLT) Operating cash flow 2024–2025
MapLight Therapeutics, Inc. (MPLT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$138.1MFY2025 · since FY2024: -$78.8M → -$138.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$138.1M | -75.3% |
| FY2024 | -$78.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MPLT financial trends
MPLT RevenueMPLT Net incomeMPLT Net marginMPLT Gross profitMPLT Gross marginMPLT Operating incomeMPLT Operating marginMPLT Free cash flowMPLT Capital expendituresMPLT Return on equityMPLT Stock buybacksMPLT Dividends paidMPLT Total assetsMPLT Total liabilitiesMPLT Shareholders’ equityMPLT overview →